Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1967]

Editor's Choice for June 2016

Prof Gordon McVie - ecancer Editor in Chief

Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )

Mutations associated with imatinib response in CML

Katerina Machova Polakova - Institute of Hematology and Blood Transfusion...

Mutations associated with imatinib response in CML ( Katerina Machova Polakova - Institute of Hematology and Blood Transfusion, Prague, Czech Republic )

Inpatient palliative care intervention in patients hospitalized for HSCT

Dr Areej El-Jawahri - Massachusetts General Hospital, Boston, USA

Inpatient palliative care intervention in patients hospitalized for HSCT ( Dr Areej El-Jawahri - Massachusetts General Hospital, Boston, USA )

Latest in precision cancer medicine

Prof Richard Schilsky - Chief Medical Officer, ASCO

Latest in precision cancer medicine ( Prof Richard Schilsky - Chief Medical Officer, ASCO )

CD19 CAR T-cells effective with with low dose chemotherapy.

Dr Stephanie Goff - National Cancer Institute, Bethesda, USA

CD19 CAR T-cells effective with with low dose chemotherapy. ( Dr Stephanie Goff - National Cancer Institute, Bethesda, USA )

Specific mutations in leukaemia patients' blood predicts survival

Dr Klaus Metzeler - University of Munich, Munich, Germany

Specific mutations in leukaemia patients' blood predicts survival ( Dr Klaus Metzeler - University of Munich, Munich, Germany )

Causes and consequences of microRNA dysregulation in cancer

Prof Carlo Croce - Ohio State University, Columbus, USA

Causes and consequences of microRNA dysregulation in cancer ( Prof Carlo Croce - Ohio State University, Columbus, USA )

Sequencing multiple myeloma reveals a complex landscape of genetic lesions

Dr Niccolo Bolli - University of Milan, Milan, Italy

Sequencing multiple myeloma reveals a complex landscape of genetic lesions ( Dr Niccolo Bolli - University of Milan, Milan, Italy )

Results from SCHOLAR-1 trial for DLBCL patients

Prof Christian Gisselbrecht - LYSARC, Pierre-Bénite, France

Results from SCHOLAR-1 trial for DLBCL patients ( Prof Christian Gisselbrecht - LYSARC, Pierre-Bénite, France )

Super-enhancer analysis reveals subtypes in AML and MDS

Dr Michael McKeown - Syros Pharmaceuticals, Cambridge, USA

Super-enhancer analysis reveals subtypes in AML and MDS ( Dr Michael McKeown - Syros Pharmaceuticals, Cambridge, USA )

PD-1 enhances elotuzumab efficacy

Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA

PD-1 enhances elotuzumab efficacy ( Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA )

Better screening programmes needed for haematological malignancies such as...

Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany

Better screening programmes needed for haematological malignancies such as leukaemia ( Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany )

More from ecancer